Company: RGBP
Filing Date: 2025-12-05
Form Type: 253G1
Source: 0001493152-25-026350
Chunk: 30

Company: Regen BioPharma Inc
Filing Date: 2025-12-05
Form: 253G1
Chunk 30
---
 On March 23, 2021 David R. Koos was appointed Chief Executive Officer, President, Secretary and Treasurer of KCL Therapeutics, Inc.

<div align='center'>22</div>

KCL Therapeutics, Inc. is a wholly owned subsidiary of Regen Biopharma, Inc.

Education:

DBA - Finance (December 2003)

Atlantic International University

Ph.D. - Sociology (September 2003)

Atlantic International University

MA - Sociology (June 1983)

University of California - Riverside, California

Employment History:

David R. Koos, 62 has served as Chairman of the Board of Directors, Chief Executive Officer, President, Secretary and Treasurer of SYBLEU INC., a biotechnology company, from June 12, 2020 to December 13, 2022. David R. Koos served as Chief Financial Officer of SYBLEU INC. from June 12, 2020 to July 21, 2020. On March 23, 2021 David R. Koos assumed the position of sole officer and director of Zander Therapeutics, Inc., a biotechnology company.

| Position:                                                                                                             
 Chairman, President, Chief Executive Officer, Secretary, Acting Chief Financial Officer, Principal Accounting Officer |     | Company Name:                                     
 Entest Group, Inc.                                |     | Employment Dates:                                                                                                                  
 June 19, 2009 to November 28, 2018                                                                                                 |
|:----------------------------------------------------------------------------------------------------------------------|:----|:--------------------------------------------------|:----|:-----------------------------------------------------------------------------------------------------------------------------------|
| Chairman, President, Chief Executive Officer, Secretary, Chief Financial Officer, Principal Accounting Officer        |     | Entest BioMedical, Inc.(a California corporation) |     | August 22,2008 to the Present                                                                                                      |
| Chairman and CEO                                                                                                      |     | Regen BioPharma, Inc.                             |     | April 24, 2012 to January 22,2020                                                                                                  |
| Acting CFO                                                                                                            |     | Regen BioPharma, Inc.                             |     | April 24, 2012 to February 11, 2015                                                                                                |
| President                                                                                                             |     | Regen BioPharma, Inc.                             |     | May 29, 2013 to October 9, 2013                                                                                                    |
| Chairman, CEO                                                                                                         |     | Zander Therapeutics, Inc.                         |     | February 2017 to January 22,